NASDAQ
QTRX

Quanterix Corp

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Quanterix Corp Stock Price

Vitals

Today's Low:
$25.05
Today's High:
$26.33
Open Price:
$25.15
52W Low:
$8.02
52W High:
$28.77
Prev. Close:
$24.32
Volume:
325843

Company Statistics

Market Cap.:
$1.01 billion
Book Value:
9.46
Revenue TTM:
$111.96 million
Operating Margin TTM:
-41.93%
Gross Profit TTM:
$46.81 million
Profit Margin:
-58.78%
Return on Assets TTM:
-6.39%
Return on Equity TTM:
-17.3%

Company Profile

Quanterix Corp had its IPO on 2017-12-07 under the ticker symbol QTRX.

The company operates in the Healthcare sector and Medical Devices industry. Quanterix Corp has a staff strength of 3,200 employees.

Stock update

Shares of Quanterix Corp opened at $25.15 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $25.05 - $26.33, and closed at $25.53.

This is a +4.98% increase from the previous day's closing price.

A total volume of 325,843 shares were traded at the close of the day’s session.

In the last one week, shares of Quanterix Corp have slipped by -5.34%.

Quanterix Corp's Key Ratios

Quanterix Corp has a market cap of $1.01 billion, indicating a price to book ratio of 1.2923 and a price to sales ratio of 4.4708.

In the last 12-months Quanterix Corp’s revenue was $111.96 million with a gross profit of $46.81 million and an EBITDA of $-41543000. The EBITDA ratio measures Quanterix Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Quanterix Corp’s operating margin was -41.93% while its return on assets stood at -6.39% with a return of equity of -17.3%.

In Q2, Quanterix Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 32%.

Quanterix Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-1.78 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Quanterix Corp’s profitability.

Quanterix Corp stock is trading at a EV to sales ratio of 1.6652 and a EV to EBITDA ratio of -2.4709. Its price to sales ratio in the trailing 12-months stood at 4.4708.

Quanterix Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$429.21 million
Total Liabilities
$31.95 million
Operating Cash Flow
$-648000.00
Capital Expenditure
$648000
Dividend Payout Ratio
0%

Quanterix Corp ended 2024 with $429.21 million in total assets and $0 in total liabilities. Its intangible assets were valued at $429.21 million while shareholder equity stood at $355.36 million.

Quanterix Corp ended 2024 with $0 in deferred long-term liabilities, $31.95 million in other current liabilities, 37000.00 in common stock, $-414329000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $329.53 million and cash and short-term investments were $329.53 million. The company’s total short-term debt was $3,986,000 while long-term debt stood at $0.

Quanterix Corp’s total current assets stands at $379.06 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $24.42 million compared to accounts payable of $3.24 million and inventory worth $18.16 million.

In 2024, Quanterix Corp's operating cash flow was $-648000.00 while its capital expenditure stood at $648000.

Comparatively, Quanterix Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$25.53
52-Week High
$28.77
52-Week Low
$8.02
Analyst Target Price
$28.25

Quanterix Corp stock is currently trading at $25.53 per share. It touched a 52-week high of $28.77 and a 52-week low of $28.77. Analysts tracking the stock have a 12-month average target price of $28.25.

Its 50-day moving average was $24.4 and 200-day moving average was $17.28 The short ratio stood at 1.95 indicating a short percent outstanding of 0%.

Around 849.2% of the company’s stock are held by insiders while 9003.3% are held by institutions.

Frequently Asked Questions About Quanterix Corp

The stock symbol (also called stock or share ticker) of Quanterix Corp is QTRX

The IPO of Quanterix Corp took place on 2017-12-07

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$0.03
0
+1.51%
$357.65
-18.25
-4.86%
$10.29
0
0%
$6.08
-0.27
-4.25%
$23.16
0.26
+1.15%
$0.02
-0
-4.76%
$9.75
0.04
+0.42%
$9.51
0.02
+0.21%
$118.2
-8.4
-6.64%
NuCana PLC (NCNA)
$0.62
-0.03
-3.93%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company’s products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Address

Building 1, Billerica, MA, United States, 01821